2023-12-12 09:16:48
She is still talked regarding. The Sanofi factory in Mourenx (Pyrénées-Atlantiques), which produces the drug Dépakine, released quantities of bromopropane more than 75 times higher than the authorized threshold, in mid-November, we learned on Monday from consistent sources, confirming a log information The world.
On December 6, company representatives in Mourenx informed the Lacq basin site monitoring committee of these rejections, which brings together industrialists, associations, elected officials and state services. On November 15, “for one hour”, “156 mg/m3 of bromopropane, instead of 2 mg/m3”, were released into the atmosphere, according to Patrick Mauboulès, president of the local environmental protection association. environment Sepanso 64, present at the meeting.
Bromopropane, recognized as carcinogenic, mutagenic and possibly reprotoxic by the WHO, is included in the composition of Dépakine, an antiepileptic drug in the sights of several associations for its effects on pregnant women.
In 2018, Sanofi defends an isolated overrun
In 2018, the Sanofi factory was shut down following the revelation by the France Nature Environnement (FNE) association of non-standard toxic discharges of sodium valproate, the subject of an investigation opened since August 2022 for “implementation in danger of others” at the public health center of the Paris judicial court.
Contacted on Monday, the Sanofi group mentioned an “isolated and very brief event, linked to the degradation of the activated carbons in the treatment unit following the severe bad weather which affected the region in the preceding days”. The company says it “immediately stopped production and informed the relevant authorities”.
Once the coals – used for the treatment of atmospheric emissions – were replaced, “bromopropane emissions returned to compliance”, adds the pharmaceutical group, specifying that “this isolated exceedance is the only one recorded since 2018”.
Alerted, state services carried out “a reactive inspection” on November 24 and, following restarting the installations on November 28, a control “during the first three days”. “The results of analyzes carried out by an external laboratory demonstrate the return to compliance of bromopropane discharges,” indicated the prefecture. “This still raises questions regarding the structure, when we were already caught by the police five years ago,” noted Jean-Louis Peyren, CGT delegate.
On November 15, a mother of two children “suffering from neuro-behavioral disorders” who worked, during her pregnancies, “opposite” the Sanofi factory in Mourenx, filed a complaint in Paris for “unintentional injuries”.
1702377699
#nonstandard #discharges #Sanofi #factory
